Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cross-Linked vs Non-Cross-Linked Hyaluronic Acid for Subdeltoid Bursitis
NCT06508125Phase 4Not yet recruiting
- Sponsor
- Taipei Medical University
- Start
- Jul 2024
- Primary completion
- Dec 2024
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of hyaluronic acid in subdeltoid bursitis, sponsored by Taipei Medical University. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
hyaluronic acid
03
Conditions
subdeltoid bursitis
Beyond the preview
Go deeper on NCT06508125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06508125.